MR1 and inflammatory bowel disease: In particular, attention should be given to clarifying how symbiotic bacterial metabolites finely regulate their activation thresholds and cytokine secretion profiles through MR1‐dependent or nondependent pathways, thereby explaining their contradictory behaviors in diseases such as IBD and tumors.